MUMBAI : The World Health Organization (WHO) is in talks with vaccine makers to start a solidarity trial for covid-19 vaccines that is modelled on the lines of a global solidarity trial for therapeutics, said people aware of the development.
The aim of the solidarity trial for vaccines that are in the early and mid-stage of clinical trials is to test vaccine efficacy across different geographies that could help speed up the regulatory process and also ensure that vaccine makers have diversity in their trial participants that could help establish vaccine effectiveness across different ethnic and racial groups.
A WHO spokesperson asked for additional details to respond to queries from Mint. Vaccine makers in India and South Africa are in